Skip to main content
. 2021 Apr 16;12:618172. doi: 10.3389/fphar.2021.618172

TABLE 2.

Major clinical research and epidemiological studies conducted to date.

SI No Population Number of subjects Cancer research Conclusion of the study References
1 Malaysia 62 (cases and control each) Breast cancer Breast cancer is associated with low serum selenium levels Rejali et al. (2007)
2 Poland 95 lung cancer, 113 laryngeal cancer, and corresponding controls Lung and laryngeal cancers Selenium level below 60 μg/L is associated with lung and laryngeal cancer Jaworska et al. (2013)
3 Baltimore longitudinal study 52 (cases) and 96 (controls)  Prostate cancer The risk of prostate cancer is high in low plasma selenium cases Brooks et al. (2001)
4 The university of California, san francisco, California 568 with non-metastatic prostate cancer Prostate cancer Genetic variation in selenoproteins may be associated with high-grade disease and recurrence of prostate cancer Gerstenberger et al. (2015)
5 Netherland 64 esophageal squamous cell carcinoma, 112 esophageal adenocarcinomas, and 114 gastric cardia adenocarcinoma cases  Esophageal and gastric cancer There is an inverse association between toenail selenium and risk of esophageal squamous cell carcinoma, esophageal adenocarcinoma, and gastric cardia adenocarcinoma Steevens et al. (2010)
6 University of North Carolina hospital, North Carolina 133 cases Colorectal adenoma The prevalence of colorectal adenoma is less with high selenium levels Connelly Frost et al. (2006)
7 Swedish 3,146 cases Breast cancer The survival rate is higher among the subjects who take selenium before the diagnosis of breast cancer Harris et al. (2012)
8 Eastern United States of America 1,312 cases Prostate cancer Selenium reduces prostate cancer incidence Duffield-Lillico et al. (2003)
9 Szczecin, Poland 546 cases Breast cancer Selenium level greater than 64.4 µg//L may be beneficial for breast cancer outcome Lubinski et al. (2018)
10 Poland 97 (cases) Women with any cancer The serum level of selenium level should be maintained between 70 and 90 μg/L for protection against cancer Narod et al. (2019)
184 (control)